We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/5/2020 16:22 | Ladies n gents the good news is ftse 100 is on the Rise Again 😆 | riz000 | |
20/5/2020 16:10 | Just look at the price fluctuations or shall I say manipulation going on . | abdullla | |
20/5/2020 15:40 | They say invest for long term but GSK shareprice below what it was 25 years ago. | montyhedge | |
20/5/2020 15:36 | borrowed one l omitted another l so much for your facts | billionairepaddy | |
20/5/2020 15:16 | I am just taking facts. | abdullla | |
20/5/2020 15:11 | abdullla do you ever have any good news about any share what shares to you invest in | billionairepaddy | |
20/5/2020 15:06 | Too much fluctuations in the share price all in the matter of one trading day does not look good for GSK as compared to other pharmas,a historically low price in the market makes it an easy manipulation target. | abdullla | |
19/5/2020 08:55 | Global IP is a big issue. IP needs controlling agreed, but giving a free access is very dangerous. The US is preparing to publicly disassociate itself from language in a World Health Organization resolution that will back the right of poor countries to ignore patents in order to gain access to a Covid-19 vaccine or treatment. Many governments, particularly in Africa, fear they will be squeezed out by richer countries unless they can force companies that discover anti-Covid therapies to share their intellectual property with manufacturers able to produce them cheaply at scale. (More in FT) | alphorn | |
19/5/2020 08:33 | Or ….. look at this work: Vir Biotechnology Inc. shares were up 31.5% to $39.90 in morning trading. Before the market open, Vir said research findings from the company's efforts to develop therapeutics for Covid-19 were published in the journal Nature. The paper, entitled "Cross-neutralizatio Vir said it is advancing two clinical development candidates based on the S309 antibody as potential therapeutics for Covid-19, VIR-7831 and VIR-7832, in collaboration with GlaxoSmithKline PLC. "Remarkably, we believe S309 likely covers the entire family of related coronaviruses, which suggests that, even as SARS-CoV-2 continues to evolve, it may be quite challenging for it to become resistant to the neutralizing activity of S309," said Herbert "Skip" Virgin, chief scientific officer of Vir. Clinical testing is expected to begin this summer in collaboration with GSK, the company said. | tradermichael | |
18/5/2020 16:16 | I suggest you read up on the work that Oxford Uni does in its micro and macro biology labs | bothdavis | |
18/5/2020 16:12 | Yes but this money should have been allocated to top of the range vaccine makers not some uni. | abdullla | |
18/5/2020 15:54 | Abdullah....it would be money well spent if it ssaves lives. | bothdavis | |
18/5/2020 15:51 | Government has paid 250 Million pounds to this Oxford +AZN adventure so far,are they making the monkey out of the taxpayers ? | abdullla | |
18/5/2020 14:57 | Doubts over vaccine.https://www. | montyhedge | |
18/5/2020 09:52 | What is the news about the GSK vaccine plant under construction in California? | abdullla | |
18/5/2020 08:52 | GSK in bed with Sanofi on Covid vaccine, they are getting funding from US gov't. | rogerrail | |
18/5/2020 08:51 | GlaxoSmithKline PLC said Monday that interim analysis of the HIV Prevention Trials Network 083 study has proved the efficacy and safety of investigational, long-acting, injectable cabotegravir inhibitor for HIV prevention. | tradermichael | |
18/5/2020 05:43 | Looks like Astra beat them to it with Coronavirus vaccine if one found, to produce 100m from the gov. | montyhedge | |
16/5/2020 11:06 | Well....your a cheerful one Abdullah!! Can't stay indoors ... got to go to work! | bothdavis | |
16/5/2020 10:48 | Perhaps Glaxo should team up with AVANCTA to deliver their groundbreaking AFFIMER technology. Any thoughts? | squintyflinty1 | |
16/5/2020 10:07 | It's all profit taking,out there except pharmas all the industry is dying,hedge funds are finding hard to survive due to the collapse and bankruptcies of blue chip Ftse100 companies,at the first opportunity hedgehogs run to sell to make as little profit they can for survival and there is no end in sight,black death is looming beware and stay indoors. | abdullla | |
15/5/2020 11:48 | Can't see the attraction dividend, the dividend boys wanted 19p dividend but loss 80p of capital, has they chased it up, crazy. | montyhedge | |
15/5/2020 09:21 | Whenever I see charts 'Emperor's new clothes' always seems to pop into my mind ... | daveboy1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions